Effects of pravastatin therapy on serum lipids and coronary reactivity are not associated with SREBP cleavage-activating protein polymorphism in healthy young men

Clin Genet. 2001 Oct;60(4):319-21. doi: 10.1034/j.1399-0004.2001.600413.x.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analysis of Variance
  • Blood Flow Velocity / drug effects
  • Coronary Artery Disease / genetics
  • Coronary Circulation / drug effects*
  • Coronary Circulation / genetics
  • Electrocardiography
  • Follow-Up Studies
  • Genotype
  • Heart / drug effects*
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Lipids / blood*
  • Male
  • Membrane Proteins / genetics*
  • Phenotype
  • Polymorphism, Genetic / genetics*
  • Pravastatin / pharmacology*

Substances

  • Intracellular Signaling Peptides and Proteins
  • Lipids
  • Membrane Proteins
  • SREBP cleavage-activating protein
  • Pravastatin